837 related articles for article (PubMed ID: 29484560)
1. The effects of 3% diquafosol sodium eye drop application on meibomian gland and ocular surface alterations in the Cu, Zn-superoxide dismutase-1 (Sod1) knockout mice.
Ikeda K; Simsek C; Kojima T; Higa K; Kawashima M; Dogru M; Shimizu T; Tsubota K; Shimazaki J
Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):739-750. PubMed ID: 29484560
[TBL] [Abstract][Full Text] [Related]
2. The effects of 3% diquafosol sodium application on the tear functions and ocular surface of the Cu,Zn-superoxide dismutase-1 (Sod1)-knockout mice.
Kojima T; Dogru M; Ibrahim OM; Nagata T; Higa K; Shimizu T; Shirasawa T; Satake Y; Shimazaki S; Shimazaki J; Tsubota K
Mol Vis; 2014; 20():929-38. PubMed ID: 24991185
[TBL] [Abstract][Full Text] [Related]
3. Changes in Tear Volume after 3% Diquafosol Treatment in Patients with Dry Eye Syndrome: An Anterior Segment Spectral-domain Optical Coherence Tomography Study.
Lee KB; Koh KM; Kwon YA; Song SW; Kim BY; Chung JL
Korean J Ophthalmol; 2017 Aug; 31(4):306-312. PubMed ID: 28752695
[TBL] [Abstract][Full Text] [Related]
4. The Role of 2% Rebamipide Eye Drops Related to Conjunctival Differentiation in Superoxide Dismutase-1 (Sod1) Knockout Mice.
Kojima T; Simsek C; Igarashi A; Aoki K; Higa K; Shimizu T; Dogru M; Tsubota K; Shimazaki J
Invest Ophthalmol Vis Sci; 2018 Mar; 59(3):1675-1681. PubMed ID: 29625494
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress induced age dependent meibomian gland dysfunction in Cu, Zn-superoxide dismutase-1 (Sod1) knockout mice.
Ibrahim OM; Dogru M; Matsumoto Y; Igarashi A; Kojima T; Wakamatsu TH; Inaba T; Shimizu T; Shimazaki J; Tsubota K
PLoS One; 2014; 9(7):e99328. PubMed ID: 25036096
[TBL] [Abstract][Full Text] [Related]
6. The Effect of Topical Diquafosol Tetrasodium 3% on Dry Eye After Cataract Surgery.
Baek J; Doh SH; Chung SK
Curr Eye Res; 2016 Oct; 41(10):1281-1285. PubMed ID: 27049809
[TBL] [Abstract][Full Text] [Related]
7. Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition.
Shigeyasu C; Yamada M; Akune Y; Tsubota K
Jpn J Ophthalmol; 2015 Nov; 59(6):415-20. PubMed ID: 26310103
[TBL] [Abstract][Full Text] [Related]
8. Effects of eye drops containing a mixture of 3% diquafosol sodium and tocopherol acetate (vitamin E) on the ocular surface of murine dry eye.
Li L; Jin R; Li Y; Yoon HS; Yoon HJ; Yoon KC
Cutan Ocul Toxicol; 2021 Dec; 40(4):350-358. PubMed ID: 34496685
[TBL] [Abstract][Full Text] [Related]
9. Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial.
Park DH; Chung JK; Seo DR; Lee SJ
Am J Ophthalmol; 2016 Mar; 163():122-131.e2. PubMed ID: 26685791
[TBL] [Abstract][Full Text] [Related]
10. Tear film lipid layer increase after diquafosol instillation in dry eye patients with meibomian gland dysfunction: a randomized clinical study.
Fukuoka S; Arita R
Sci Rep; 2019 Jun; 9(1):9091. PubMed ID: 31235821
[TBL] [Abstract][Full Text] [Related]
11. Influence of Ophthalmic Solutions on Tear Components.
Shigeyasu C; Yamada M; Akune Y
Cornea; 2016 Nov; 35 Suppl 1():S71-S77. PubMed ID: 27661071
[TBL] [Abstract][Full Text] [Related]
12. Age-Related Conjunctival P2Y2 Receptor Alterations in the Cu, Zn-Superoxide Dismutase-1 (Sod1)-Knockout Dry Eye Model Mice.
Dogru M; Shinzawa M; Kojima T; Shimizu T; Tsubota K
Eye Contact Lens; 2019 Nov; 45(6):405-409. PubMed ID: 30908311
[TBL] [Abstract][Full Text] [Related]
13. The effects of 2% rebamipide ophthalmic solution on the tear functions and ocular surface of the superoxide dismutase-1 (sod1) knockout mice.
Ohguchi T; Kojima T; Ibrahim OM; Nagata T; Shimizu T; Shirasawa T; Kawakita T; Satake Y; Tsubota K; Shimazaki J; Ishida S
Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7793-802. PubMed ID: 24168989
[TBL] [Abstract][Full Text] [Related]
14. Effects of Diquafosol Ophthalmic Solution on Quality of Life in Dry Eye Assessed Using the Dry Eye-Related Quality-of-Life Score Questionnaire: Effectiveness in Patients While Reading and Using Visual Display Terminals.
Utsunomiya T; Kawahara A; Hanada K; Yoshida A
Cornea; 2017 Aug; 36(8):908-914. PubMed ID: 28542084
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease.
Mun Y; Kwon JW; Oh JY
BMC Ophthalmol; 2018 Sep; 18(1):237. PubMed ID: 30185156
[TBL] [Abstract][Full Text] [Related]
16. Impact of Diquafosol Ophthalmic Solution on Tear Film and Dry Eye Symptom in Type 2 Diabetic Dry Eye: A Pilot Study.
Zhang Q; Zhang H; Qin G; Wu Y; Song Y; Yang L; Yu S; He X; Moore JE; Moutari S; Palme C; Xu L; He W; Pazo EE
J Ocul Pharmacol Ther; 2022 Mar; 38(2):133-140. PubMed ID: 35049373
[No Abstract] [Full Text] [Related]
17. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial.
Matsumoto Y; Ohashi Y; Watanabe H; Tsubota K;
Ophthalmology; 2012 Oct; 119(10):1954-60. PubMed ID: 22739038
[TBL] [Abstract][Full Text] [Related]
18. Topical diquafosol for patients with obstructive meibomian gland dysfunction.
Arita R; Suehiro J; Haraguchi T; Maeda S; Maeda K; Tokoro H; Amano S
Br J Ophthalmol; 2013 Jun; 97(6):725-9. PubMed ID: 23584719
[TBL] [Abstract][Full Text] [Related]
19. Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye.
Tauber J; Davitt WF; Bokosky JE; Nichols KK; Yerxa BR; Schaberg AE; LaVange LM; Mills-Wilson MC; Kellerman DJ
Cornea; 2004 Nov; 23(8):784-92. PubMed ID: 15502479
[TBL] [Abstract][Full Text] [Related]
20. Effects of diquafosol sodium eye drops on tear film stability in short BUT type of dry eye.
Shimazaki-Den S; Iseda H; Dogru M; Shimazaki J
Cornea; 2013 Aug; 32(8):1120-5. PubMed ID: 23635860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
